Shire-AbbVie deal collapses: What next?

Abbvie has called time on its $54 billion offer for Ireland-based Shire, after its board said it would no longer recommend the bid to shareholders.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.